Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The 23S ribosomal RNA (rRNA) domain V in Helicobacter pylori is a critical structural and functional component of the bacterial 50S ribosomal subunit. It forms the core of the peptidyl transferase center (PTC), which is responsible for catalyzing peptide bond formation during protein synthesis (Taylor et al., 1997, Antimicrob. Agents Chemother.). This domain is the primary therapeutic target for macrolide antibiotics, such as clarithromycin, which is a cornerstone of H. pylori eradication therapy (Megraud, 2004, Gut). Macrolides bind to specific nucleotides within domain V, effectively blocking the nascent peptide exit tunnel and halting translation (Vester & Douthwaite, 2001, Antimicrob. Agents Chemother.). Mutations within this domain, particularly at positions A2142 and A2143, are the leading cause of clinical resistance to clarithromycin (Versalovic et al., 1996, Antimicrob. Agents Chemother.). These mutations significantly impact the efficacy of treatment regimens for H. pylori-associated conditions like peptic ulcers and gastric cancer (Mégraud & Lehours, 2007, Clin. Microbiol. Rev.). Understanding the structural integrity of domain V is essential for monitoring antibiotic susceptibility and developing next-generation antimicrobial agents.
Inhibition of bacterial protein synthesis by binding to the 23S rRNA and blocking the nascent peptide exit tunnel.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori 23S ribosomal RNA domain V (23S rRNA domain V) (23S rRNA domain V).